This is a working overview of GIP receptor, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-02-26. Anything still debated is marked as such rather than presented as settled.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
An extended fatty diacid moiety promotes binding to serum albumin, which slows renal clearance and extends the circulating half-life to roughly five days. That property supports once-weekly administration and largely explains the dosing interval described in clinical reports. Published data come mainly from large randomised programmes that evaluated glycaemic control and body weight over periods of many months. Long-term outcomes beyond those trial windows, including what happens after treatment stops, remain an active area of investigation.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 39-residue peptide | GIP-derived backbone with non-natural residues |
| Molar mass | Approximately 4.8 kDa | Peptide chain plus linker and lipid modifications |
| Appearance | White to off-white powder | Typical of lyophilized research material |
| Solubility | Soluble in water and aqueous buffer | Practically insoluble in nonpolar solvents |
| Storage temperature | Typically −20 °C for dry powder | Solutions usually held at 2–8 °C short term |
Tirzepatide 是一种由 39 个氨基酸组成的合成肽，分子结构上以 GIP 序列为骨架并引入脂肪酸侧链修饰，使其能够同时与葡萄糖依赖性促胰岛素多肽（GIP）受体和胰高血糖素样肽-1（GLP-1）受体结合。这种双重激动特性使它在同类肽类药物中区别于选择性 GLP-1 受体激动剂。该分子最早由一家制药公司在 2010 年代报道，随后进入糖尿病与体重管理领域的临床研究。
在生理层面，GIP 与 GLP-1 均为肠道内分泌细胞分泌的肠促胰素，进食后参与胰岛素分泌调节与胃排空抑制。Tirzepatide 通过同时激活这两条信号通路，使胰岛素分泌的葡萄糖依赖性增强，并延缓冲胃排空、降低食欲信号。与单一 GLP-1 激动相比，双靶点作用在血糖控制和体重变化上的效应幅度更大，但具体贡献比例仍在研究之中。
脂肪酸侧链的存在使该肽与血浆白蛋白结合能力增强，从而延长循环半衰期，支持每周一次给药的用药间隔。白蛋白结合同时改变组织分布特征，减慢肾脏清除速度。该设计思路在多种长效肽类药物中被反复采用，属于既定的药代动力学策略。
Development of tirzepatide took place under a research program that sought to test whether simultaneous engagement of two incretin receptors would produce greater metabolic effects than single-receptor agonism. Clinical trials were organized into the SURPASS series for type 2 diabetes and the SURMOUNT series for obesity and weight management. Regulatory clearance for type 2 diabetes came in 2022 in the United States, followed by approval for chronic weight management in 2023. The trial programs reported reductions in glycated hemoglobin and body weight relative to comparators, though long-term cardiovascular and durability data continue to accumulate.
The peptide backbone contains 39 amino acids and includes alpha-aminoisobutyric acid residues, which are not among the standard proteinogenic set. A C20 fatty diacid moiety is attached through a linker, allowing the compound to bind serum albumin and extend its circulation time. This albumin binding is the main reason the molecule supports once-weekly administration rather than more frequent dosing. The measured molecular mass is approximately 4,813 daltons, placing it firmly in the peptide rather than small-molecule class.
Pre-preg allows one to impregnate the fibers on a flat workable surface, or rather in an industrial process, and then later form the impregnated fibers to a shape which could prove to be problematic for the hot injection process. Pre-preg also allows one to impregnate a bulk amount of fiber and then store it in a cooled area (below 20 °C) for an extended period of time to cure later. The process can also be time-consuming in comparison to the hot injection process and the added value for pre-preg preparation is at the stage of the material supplier.
Some sources consider these movies to be part of Season 1 of the series, particularly the second and third films, which aired only a couple of months before the weekly series began. All three films were later re-edited into two-part episodes of the regular series, with additional footage added, for the purposes of network reruns and later syndication. In all three cases, the original opening titles are removed and replaced with the standard Six Million Dollar Man title sequence. In the case of "The Moon and the Desert", some of the additional footage consisted of clips from later seasons, including footage of Martin E. Brooks as Rudy Wells, even though Martin Balsam plays the character in the first telefilm, and operation footage from "The Bionic Woman" episode of season 2.
==== N-acetylcysteine and triple therapy ==== N-Acetylcysteine (NAC) is a precursor to glutathione, an antioxidant. It has been hypothesized that treatment with high doses of NAC may repair an oxidant–antioxidant imbalance that occurs in the lung tissue of patients with IPF. In the first clinical trial of 180 patients (IFIGENIA), NAC was shown in previous study to reduce the decline in VC and DLCO over 12 months of follow-up when used in combination with prednisone and azathioprine (triple therapy). A large randomized, controlled trial (PANTHER-IPF) was undertaken by the National Institutes of Health (NIH) in the US to evaluate triple therapy and NAC monotherapy in IPF patients. This study found that the combination of prednisone, azathioprine, and NAC increased the risk of death and hospitalizations and the NIH announced in 2012 that the triple-therapy arm of the PANTHER-IPF study had been terminated early. This study also evaluated NAC alone and the results for this arm of the study were published in May 2014, concluding that "as compared with placebo, acetylcysteine offered no significant benefit with respect to the preservation of FVC in patients with idiopathic pulmonary fibrosis with mild-to-moderate impairment in lung function".
The saw chain, or cutting chain, is a key component of a chainsaw. It consists of steel links held together by rivets, and superficially resembles the bicycle-style roller chain, although it is closer in design to a leaf chain. Its key differences are sharp cutting teeth on the outside of the chain loop, and flat drive links on the inside, to retain the chain on the saw's bar and allow propulsion by the engine or motor. Saw chains (and chainsaws generally) are used for cutting wood. This may be for harvesting trees for pulp or timber, for tree surgery, or for processing firewood. Whether for hand-held chainsaws, mechanical timber harvesters or chain mortisers, the saw chain has undergone dramatic development since its invention. Modern chains designed for high power, high-speed sawing applications will vastly outperform older designs, while allowing a far greater degree of safety and reliability in use.
Sources: en.wikipedia.org
Medical imaging is also central in supplying the biometric data necessary to establish baseline features of anatomy and physiology so as to increase the accuracy with which early or fine-detail abnormalities are detected. These diagnostic techniques are often performed in combination with general pathology procedures and are themselves often essential to developing new understanding of the pathogenesis of a given disease and tracking the progress of disease in specific medical cases. Examples of important subdivisions in medical imaging include radiology (which uses the imaging technologies of X-ray radiography) magnetic resonance imaging, medical ultrasonography (or ultrasound), endoscopy, elastography, tactile imaging, thermography, medical photography, nuclear medicine and functional imaging techniques such as positron emission tomography. Though they do not strictly relay images, readings from diagnostics tests involving electroencephalography, magnetoencephalography, and electrocardiography often give hints as to the state and function of certain tissues in the brain and heart respectively.
=== John B. Fenn Award for a Distinguished Contribution in Mass Spectrometry (since 1990) === 2024 Jennifer Brodbelt 2023 Carol Vivien Robinson 2017 Catherine E. Costello 2012 Catherine C. Fenselau 2009 Vicki H. Wysocki
Commission C2: Food Science and Engineering Commission C2 on Food Science and Engineering focuses on research and breakthrough technologies related to food science and engineering. The commission is key in hosting the IIR Sustainability and the Cold Chain Conference (ICCC), held internationally since 2010. In addition to the Cold Chain conferences and the IIR Congress, Commission C2 has also co-sponsored four other conferences in Macedonia, Spain, Croatia and Germany, and continues to reinforce its leading role at the heart of developments in food science and engineering. The commission is involved in various IIR Working Groups and innovative projects linked to the development of the food chain across the globe.
==== Operation Enduring Freedom – Trans Sahara ==== In June 2005, the United States replaced the PSI with the launch of the Trans-Saharan Counterterrorism Initiative (TSCTI/TSCTP) for Burkina Faso, Mali, Niger, Chad, Mauritania, Morocco, Algeria, Tunisia, Senegal and Nigeria, with the support from the Department of Defense's Operation Enduring Freedom – Trans Sahara (OEF-TS). The principle SOF unit for the TSCTP/TSCTI was the 10th SFG, which was joined by the 20th SFG, as the 3rd SFG (who had regional responsibility for Africa) was assigned to Iraq. This meant the Green Berets in the region lacked the cultural and language prerequisites that the 3rd SFG had, and so the Green Berets were forced into a mission that they, like the targeted countries were "learning on the job". In 2005 and 2007, US Army Special Forces and US Army Rangers, along with contingents from other units participated in the JCET's Flintlock Exercises, where they provided training experience both for American troops and for troops of African countries. Small numbers of European troops were also involved in these exercises. The first test of the TSCTI, which "kicked off" the Saharan counterterrorism initiative was Flintlock 2005, lasted from 6–26 June 2005, and was designated by the Bush administration as the largest American military exercise in Africa since World War II. 700 special forces participants, supported by an additional 2,100 troops from 9 North and West African states.
== Early life and education == Chutia was one of the first girls to take Mathematics as a main subject in her school. She later studied physics at Cotton University, Assam where she obtained a BSc in 1967. She continued teaching at Cotton College before obtaining an MSc in physics at Dibrugarh University in 1969. Following this, Chutia taught for some time as a lecturer, eventually deciding to continue with research by pursuing a PhD at Dibrugarh University on a fellowship in 1976. Her research focused on the conduction mechanism of thin polymer films and she was awarded her degree in 1981.
Sources: en.wikipedia.org
=== Violent or major crime === Typically, cold cases are violent and other major felony crimes, such as murder and rape, which—unlike unsolved minor crimes—are generally not subject to a statute of limitations. Sometimes disappearances can also be considered cold cases if the victim has not been seen or heard from for some time, such as the case of Natalee Holloway or the Beaumont children.
As iced-tea mix As fermented mix without alcohol (vegetable or fruit juice) As a supplement for vegetable or fruit juices to intensify the sweet flavor, to increase the nutritional value, as well as to create a umami taste Light or dark hemp drink without alcohol similar to beer As a distilled hard liquor, such as hemp spirit As herb liqueur or bitter using alcohol and sugar in the production process As a mixer for alcoholic drinks such as cocktails As a brewing ingredient for hemp beer As a base for gluten-free beer Gluten-free hemp beer does not require malt or cereal mash and it is low in calories. Hemp as a close relative of hops provides the fine and bitter beer taste even without using any hops.
1998 A record for the duration of life among males. The Danish-American Christian Mortensen lived 115 years and 252 days. 1998 Scientists managed to extend, in a laboratory environment, the life of normal human cells beyond the Hayflick limit using telomerase. 1999 Establishment of the Buck Institute for Research on Aging – the first institute originally established primarily to study intervention into the aging process. 1999 Sierra Sciences, a biotechnology company focused on aging research with the goal of curing human aging, was founded by William H. Andrews.
=== Structural domains === All of the isoforms of CaMKII have: a catalytic domain, an autoinhibitory regulatory domain, a variable segment, and a self-association domain. The catalytic domain binds ATP and substrate proteins; it is responsible for the transfer of phosphate from ATP to Ser or Thr residues in the substrate proteins. The autoinhibitory regulatory domain features a pseudosubstrate site, which binds to the catalytic domain and blocks its ability to phosphorylate proteins. The structural feature that governs this autoinhibition is the Threonine 286 residue. Phosphorylation of this site will permanently activate the CaMKII enzyme. Once the Threonine 286 residue has been phosphorylated, the inhibitory domain is blocked from the pseudosubstrate site. This effectively blocks autoinhibition, allowing for permanent activation of the CaMKII enzyme. This enables CaMKII to be active, even in the absence of calcium and calmodulin. The other two domains in CaMKII are the variable and self-association domains. Differences in these domains contribute to the various CaMKII isoforms. The self-association domain (CaMKII AD) is found at the C terminus, the function of this domain is the assembly of the single proteins into large (8 to 14 subunits) multimers.
Sources: en.wikipedia.org
It acts as an agonist at both the GIP and GLP-1 receptors, two related class B G protein-coupled receptors. This dual activity distinguishes it from single-receptor GLP-1 agonists. The clinical consequences of engaging both receptors are still being characterized.
It is given by subcutaneous injection, generally on a weekly schedule. Dosing usually begins low and increases in steps to limit gastrointestinal side effects. Formulated product is supplied as a ready-to-use pen or vial in most markets.
No. Receptor engagement is documented, but how central appetite circuits, gut signals, and insulinotropic effects combine is incompletely resolved. Investigators continue to separate GIP-driven from GLP-1-driven contributions in animal and human models.
It acts as a dual agonist at the GIP receptor and the GLP-1 receptor. This broader targeting profile distinguishes it from selective GLP-1 agonists, which engage only one receptor.